2017-11-14 08:00
Uppsala, Sweden, November 14, 2017. Results from a study of 142 women with newly diagnosed metastatic breast cancer will be presented by researchers from Lund University at the world’s biggest breast cancer conference in San Antonio, USA. The study...
2017-11-08 09:00
Uppsala, Sweden, November 8, 2017. Mattias Bergqvist, VP Clinical Development at Biovica is invited to talk at the 13th Annual Biomarkers Congress 15-16 February 2018, Manchester, UK. As part of the congress Mattias will present at a free webinar on...
2017-11-06 09:00
Uppsala, Sweden, November 6. 2017. The Facebook Group " Aktier – Småbolagsjakten " organizes a live QA session with Biovica International's CEO Anders Rylander on November 20, 2017 between 19.00 - 20.00.
2017-05-22 14:00
Uppsala, Sweden, May 22 2017. Samuel Rotstein has been appointed as Scientific Advisor to Biovica.
2017-05-04 10:00
Uppsala, Sweden, May 4 2017. Biovica has received an order for the company's product DiviTum® from a global contract research company (CRO company), commissioned by a global pharmaceutical company to study the effectiveness of new cancer drugs.
2017-04-11 09:30
Lund University select Biovicas DiviTum® assay for inclusion in a study of 150 women with metastatic breast cancer. The purpose of the study is faster evaluation of treatment efficacy than current standard methods. Lund University will buy about 550...
2017-04-07 09:00
Biovica will participate in a EUROSTAR research project called SUBLYME, that will develop a new targeted drug for blood cancer. For Biovica the project expand the application of DiviTum® to one of the most common forms of blood cancer where the incidence...
2017-04-03 17:30
Uppsala, Sweden, April 3 2017. The latest data of the DiviTum® assay as an efficacy marker of CDK4/6 inhibition was presented in an oral session by Dr. Geoffrey Shapiro, Dana-Farber Cancer Institute, at the 2017 American Association for Cancer Research...
2017-02-22 14:30
Uppsala, Sweden, February 20, 2017. Biovica has strengthened its management team to ensure continued successful development. Cecilia Driving (CFO), Karin Mattsson (R&D Director) and Johanna Faris (Quality and Regulatory Assurance Director) have joined...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects